期刊文献+

不同的冻存方法对1型糖尿病患者胰岛抗原特异性T细胞反应的影响 被引量:1

Effect of cryopreservation method on islets specific T cell responses in type 1 diabetic patient
下载PDF
导出
摘要 目的:明确何种冻存方案更利于保持1型糖尿病患者的外周血单个核细胞(peripheral blood mononuclearcells,PBMCs)对胰岛抗原特异性的T细胞反应,更接近于新鲜细胞的状态。方法:本研究系国际免疫学协会-T细胞工作组(IDS-TCW)牵头的国际标准化研究Freezing Study I。中南大学糖尿病中心选取5例新发的T1D患者和年龄、性别相匹配的5例正常对照。所有对象新鲜分离的PBMCs分为3份,一份进行亚型细胞的流式细胞分析和酶联免疫斑点实验(enzyme linked immunospot assay,ELISPOT),另两等份分别采用低温和室温冻存方案冻存;1个月后分别按低温和室温方案复苏,以台盼蓝染色判定细胞活力;并行流式细胞分析术和ELISPOT检测。ELISPOT中4种抗原[包括人GAD65、内对照、Pediacel(巴斯德五合一疫苗)和PMA]均由IDS-TCW中心化实验室盲法标记,盲法测定。以新鲜PBMCs为参照,比较两种冻存方案下PBMCs的复苏率和活力、各亚型细胞比例和ELISPOT检测结果。结果:1)室温冻存下的PBMCs复苏率和细胞活力均略高于低温冻存方案,但二者差异无统计学意义(分别为61.2%vs 60.1%,77.5%vs 74.9%;P>0.05);2)相比新鲜细胞,两种冻存方案均会造成一定程度的单核细胞的损失[(3.2±1.1)%(低温)和(3.0±0.9)%(室温)vs(7.0±1.1)%(新鲜);P<0.05];而CD4+T,CD8+T,B细胞,NK细胞和NKT细胞比例均无明显变化(P>0.05);3)ELISPOT检测结果显示:对多克隆刺激物PMA诱发的T细胞分泌IFN-γ的反应,在新鲜和冻存复苏细胞间无明显差异;记忆性抗原Pediacel和胰岛抗原GAD65刺激下的特异性T细胞反应在冻存复苏细胞均明显差于新鲜细胞,T1D患者新鲜细胞的GAD特异性T细胞反应的SI为5.1,均高于低温(1.3)和室温(1.4)冻存复苏的刺激指数(SI)(均P<0.05);而且仅新鲜细胞的GAD-反应性T细胞的SI和斑点数均明显高于正常对照(5.1 vs 0.9和8.1 vs 0.1,P<0.05),而两种方案下的冻存细胞的SI在患者和对照未发现差异。结论:需要开展更多的研究,在T1D患者中鉴定出一种更接近于新鲜PBMCs反应的冻存方案和T细胞测定方法。 Objective: To explore the better freezing protocol to preserve peripheral blood monuclear cells(PBMCs),islets antigen-specific T cells responses compared with freshly isolated samples in type 1 diabetic(T1D) patients.Methods: The T cell Workshop Committee of the Immunology of Diabetes Society(IDS-TCW) organized the Freezing Study I and we were one of the 9 centers in the world to participate in the study.According to the two standardized T cell freezing protocols(warm and cold) to freshly isolated PBMCs in terms of recovery,viability,cell subset composition(FACS) and performance in Enzyme-linked immunospot(ELISPOT) assays,we chose 5 newly onset T1D patients and 5 age and sex matched healthy controls.Besides the protocols,all the freezing reagents and antigens were also centralized.The antigens used in ELISPOT were labeled blindedly.Results: 1) Although warm frozen-thawed(W) samples had a slightly higher recovery rate(61.2% vs 60.1%,P>0.05) and viability(77.5% vs 74.9%,P>0.05) as compared with the cold frozen ones(C),the difference was not significant.2) Both protocols led to a relative loss in monocytes as compared with the fresh samples(F) [3.2±1.1%(C) and 3.0±0.9%(W) vs 7.0±1.1%(F),both P<0.05],while other subsets including CD4+T,CD8+T,B cells,NK cells and NKT cells didn’t.3) Freezing and fresh samples showed similar IFN-γ secretion responses to polystimuli in ELISPOT.Irrespective of the freezing protocol,recall antigen Pediacel and islet antigen-reactive responses were both lower in the frozen cells compared with fresh PBMCs.The stimuli index(SI) of GADspecific T cell response in the fresh samples from T1D patients was 5.1,higher than that of frozen samples with either cold protocol(1.3) or warm one(1.4)(both P<0.05).Only fresh samples from T1D showed significantly higher GAD-specific T cell responses than the healthy controls no matter in SI(5.1 vs 0.9,P<0.05) or spot forming cells(8.1 vs 0.1,P<0.05),whereas the frozen samples did not show such difference.Conclusion: More studies are needed to verify a freezing method to bring comparable islets antigen specific T cell responses in T1D patients to fresh PBMCs.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2013年第2期169-175,共7页 Journal of Central South University :Medical Science
基金 国家自然科学基金(30400217) 湖南省科技厅社会发展科技支撑计划重点项目(2010SK2007) 中南大学前沿研究计划(201023100004)~~
关键词 1型糖尿病 T细胞 冻存方案 酶联免疫斑点法 type 1 diabetes T cell freezing method enzyme-linked immunospot
  • 相关文献

参考文献19

  • 1Roep BO, Peakman M. Diabetogenic T lymphocytes in human type 1 diabetes[J]. Curr Opin Immunol, 2011, 23 (6): 746-753.
  • 2Lampeter EF, Homberg M, Quabeck K, et al. Transfer of insulin- dependent diabetes between HLA-identical siblings by bone marrow transplantation[J]. Lancet, 1993, 341(8855): 1243-1244.
  • 3Seyfert-Margolis V, Gisler TD, Asare AL, et al. Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled stdyIJ]. Diabetes, 2006, 55 (9): 2588- 2594.
  • 4Herold KC, Brooks-Worrell B, Palmer J, et al. The type 1 diabetes TrialNet Research Group. Validity and Reproducibility of measurement of islet autoreactivity by T cell assays in subjects with early type 1 diabetes[J]. Diabetes Care, 2009, 58 (11): 2S88-2S9S.
  • 5James EA, Mallone R, Schloot NC, et al. Immunology of Diabetes Society T-CeU Workshop: HLA class II tetramer-directed epitope validation initiative. T-Cell Workshop Committee, Immunology of Diabetes Society[J]. Diabetes Metab Res Rev, 2011, 27 (8): 727-736.
  • 6Weinberg A, Song LY, Wilkening C, et al. for the Pediatric ACTG Cryopreservation working group. Optimization and limitations of use ocryopreserved peripheral blood mononuclear cells for functional and phenotypic T cell characterization[J]. Clin Vacc Immunol, 2009, 16 (8): 1176-1186.
  • 7Weinberg A, Song LY, Wilkening CL, et al. Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays[J]. J Immunol Methods, 2010, 363 (i): 42-50.
  • 8Mallone R, Mannering SI, Brooks-Worrell BM, et al. Isolation and preservation of peripheral blood mononuclear cells for analysis of isletantigen-reactive T cell responses: position statement of the T-Cell workshop Committee of the Immunology of Diabetes Society[J]. Clin Exp Immunol, 2011, 163 (1): 33-49.
  • 9Mannering SI, Wong FS, Durinovic-Bello I, et al. Immunology of Diabetes society T cell Workshop Committee. Current approaches to measuring human islet antigen specific T cell function in type 1 diabetes[J]. Clin Exp Immunol, 2010, 162 (2): 197-209.
  • 10Smith JG, Liu X, Kaufhold RM, et al. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus[J]. Clin Diagn Lab Immunol, 2001, 8 (5): 871-879.

同被引文献10

  • 1Walboomers JM, Jacobs MV, Manos MM, et al. Human papil- lomavirus is a necessary cause of invasive cervical cancer world- wide[J]. J Pathol,1999,159( 1 ) :12-19.
  • 2zur Hausen H. Papillomavirus infections-a major cause of hu- man cancers[ J]. Biochim Biophys Acta, 1996,1258 ( 2 ) : F55- 78.
  • 3Bontkes HJ, de Gruijl TD, Walboomers JM, et al. Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions [ J ]. Br J Cancer, 1997,76(10) : 1353-1360.
  • 4Chen L, Mizuno MT, Singhal MC, et al. Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16 [ J]. J Immunol,1992,148 (8) :2617-2621.
  • 5Schoenberger SP, Toes RE, van der Voort EI, et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions [ J ]. Nature, 1998,393 (6684) : 480-483.
  • 6Kast WM, Bronkhorst AM, de Waal LP, et al. Cooperation be- tween cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-re- stricted and MHC-regulated; a model for MHC-disease associa- tions [ J ]. J Exp Med, 1986,164 (3) :723-738.
  • 7Kim KH, Greenfield WW, Cannon MJ, et al. CD4^+ T-Cell re- sponse against Human Papillomavirus Type 16 E6 protein is as- sociated with a favorable clinical trend[ J]. Cancer Immunol Im- munother,2012,61 ( 1 ) :63-70.
  • 8Nakagawa M, Gupta SK, Coleman HN, et al. A favorable clin- ical trend is associated with CD8 T-cell immune responses to the human papillomavirus type 16 e6 antigens in women being stud- ied for abnormal pap smear results[J]. J Low Genit Tract Dis, 2010,14(2) :124-129.
  • 9Wang X, Santin AD, Bellone S, et al. A novel CD4 T-cell epitope described from one of the cervical cancer patients vacci- nated with HPV 16 or 18 E7-pulsed dendritic cells[J]. Cancer Immunol Immunother,2009,58 (2) :301-308.
  • 10彭贤贵,陈幸华,刘林,张曦,孔佩艳.-80℃条件下不同细胞浓度外周血干细胞冻存效果的实验观察[J].重庆医学,2003,32(10):1307-1308. 被引量:6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部